ASX:TRU TruScreen Group (TRU) Stock Price, News & Analysis → Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad) Free TRU Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get TruScreen Group alerts: Email Address Ad Behind the MarketsThe #1 Opportunity of the decade?It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.Click here to learn more >>> About TruScreen GroupTruscreen Group Limited, together with its subsidiaries, engages in the development, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.Read More Ad Behind the MarketsThe #1 Opportunity of the decade?It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.Click here to learn more >>> TRU Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive TRU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TruScreen Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:TRU CUSIPN/A CIKN/A Webtruscreen.com Phone61 2 90787671FaxN/AEmployees8,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,540,000.00 Net Margins-113.99% Pretax MarginN/A Return on Equity-144.54% Return on Assets-58.47% Debt Debt-to-Equity RatioN/A Current Ratio2.46 Quick Ratio3.54 Sales & Book Value Annual Sales$2.23 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares429,790,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.04 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Guy Adrian Robertson B.Com. (Age 71)B.Comm(Hons.), CA, MAICD, CFO & Company Secretary Comp: $95.27kMr. Edmond CapceleaChief Technology OfficerMr. Martin DillonInterim Chief Executive OfficerDr. . PhuncHead of Cancer DepartmentDr. . ChuongHead of Research & Development and Training DepartmentDr. . ThuyHead of High Service Gynaecology ExaminationMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersChristopher HornSold 1,346,175 sharesTotal: $26,923.50 ($0.02/share)Anthony (Tony) HoSold 600,000 sharesTotal: $15,000.00 ($0.03/share)Anthony (Tony) HoBought 150,000 shares on 7/10/2023Total: $3,900.00 ($0.03/share) This page (ASX:TRU) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TruScreen Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.